Alzheimer's disease

Law
5:45 pm
Thu July 25, 2013

A former University of Michigan neurologist could be a key witness in federal insider trading case

Dr. Sidney Gilman (file photo)
UM Photo

A huge Connecticut-based hedge fund owned by an embattled billionaire is facing insider-trading charges.    And a former University of Michigan professor may have played a part. 

Read more
Environment & Science
12:19 pm
Tue April 2, 2013

Proposed federal funding could boost U of M brain research

A model of the human brain
Life123.com

Researchers at the University of Michigan are closely watching President Obama’s call for a big increase in federal funding for brain research. 

President Obama is proposing a 100 million dollar increase in federal funding for brain research.   

U of M has many different researchers studying the human brain.    From Alzheimer’s disease to Depression, neuroscientists on the Ann Arbor campus are approaching the brain from a wide variety of specialties.

Read more
Law
2:42 pm
Tue November 20, 2012

UM professor named in $276 million insider trading scandal

From the federal government's filing against Mathew Martoma. Martoma allegedly received insider information from UM's Sidney Gilman.

In what is being called "the most lucrative insider trading scheme ever charged," federal prosecutors are filing a criminal case against Mathew Martoma, a former trader at a division of  SAC Capital.

Here's the press conference where the charges were described:

Martoma is charged with making around $276 million in avoided losses and combined profits on a deal based on insider information from a University of Michigan professor.

Read more
Arts & Culture
8:20 pm
Fri June 8, 2012

Meet me at the DIA: A journey into art, and memory

DIA docent Andrea Simons with "The Merrymakers."
Sarah Cwiek Michigan Radio

If you’ve ever watched a love one suffer through memory loss, you know they lose more than just their ability to remember even the most basic things.

They can lose their ability to relate—and become strangers to themselves, and the people who care for them.

But a new program at the Detroit Institute of Arts tries to ease that experience with what might seem like an unorthodox treatment: talking about art.

One Saturday morning: “Meet me at the DIA”

Read more
Health
12:48 pm
Wed May 16, 2012

Goal: Cure Alzheimer's disease by 2050

Ann Gordon Flickr

The National Institutes of Health has set a goal to prevent and treat Alzheimer's disease by 2050.

Henry Paulson is the director of the University of Michigan's Alzheimer's Disease Center.

"I'm a 100-percent supporter of this," he says. "This is a huge medical problem. We have over 5-million people who have Alzheimer's now in this country and as we get older, the number is increasing rapidly. So this is a crisis and although we understand a lot about the mechanisms of the disease, we still don't have effective therapies. So this push, this additional support I think will drive toward those therapies that we so desperately need."

16-million Americans are expected to have Alzheimer's disease or other forms of dementia by 2050.

The Obama Administration has allocated $50-million for Alzheimer's Research. N-I-H will spend an additional 30 million on two national studies.

"One of the things I like about the announcement yesterday is there are two major studies that they emphasize that are going to be funded right away," Paulson says. "One is a symptomatic study, that is the intranasal insulin, is looking to see if that can improve symptoms in people who have cognitive impairment. The other study is a preventative study from families who actually have inherited caused dimentia which is not what most people have."

Paulson says many investigators with the U of M's Alzheimer's Disease Center will be applying for additional funding for Alzheimer's research.

- Emily Fox, Michigan Radio Newsroom